Tag: DETOUR2
Three-year DETOUR2 results demonstrate sustained limb preservation in complex SFA disease
Endologix today announced publication of 36-month results from the DETOUR2 clinical trial evaluating percutaneous transmural arterial bypass (PTAB) using the Detour system in the...
Endologix announces 36-month results of DETOUR2 study
Endologix has announced the final 36-month results from the DETOUR2 study—a prospective, single-arm, international, multicentre clinical evaluation of the novel Detour system for fully...
